Aesthetic Enterprises has acquired Zipper Clinics to expand its network and enhance service offerings in the growing Dutch cosmetic treatment market.
Target Information
Aesthetic Enterprises operates as a prominent cosmetic treatment platform that includes the SOAP clinics, which provide a diverse range of beauty, skin, and injectable treatments across seven cities in the Netherlands. Additionally, it encompasses BM Clinics, known for delivering high-quality injectable treatments at competitive prices, with nine locations throughout the country. Both clinic chains are recognized as leaders in the rapidly expanding cosmetic treatment market, having been integrated into the Aesthetic Enterprises group since June 2024.
The recent acquisition of Zipper Clinics significantly enhances Aesthetic Enterprises' network by adding two locations in Enschede and Apeldoorn. This strategic move also introduces a new array of services, specifically small, outpatient surgical procedures like eyelid corrections. Founded in 2015 by Floortje Zipper and Michel Cromheecke, Zipper Clinics enjoys an excellent reputation for both its quality treatments and injectable services, such as Botox and fillers.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The cosmetic treatment industry in the Netherlands has experienced remarkable growth in recent years, driven by an increasing public interest in aesthetic procedures. This demand can be attributed to various factors, including societal beauty standar
Similar Deals
Oral Care → De Tandartsengroep (DTG)
2025
Asker Healthcare Group → Oudshoorn Chirurgische Techniek B.V.
2025
AVS Bio → ImmunoPrecise Antibodies (Europe) B.V.
2025
LipoCoat Holdings → Sono-Coat
2024
Arendse Group → Healthclub One
2024
Prime Care Clinics → LOOY Clinics
2024
Aesthetic Enterprises
invested in
Zipper Clinics
in 2024
in a Buy & Build / Roll-Up deal